Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yu-Kun Kuang"'
Autor:
Zi-Mu Li, Yu-Kun Kuang, Yi-Fan Zheng, Pei-Hang Xu, Ji-Yu Wang, Run-Jing Gan, Hui-Xia Li, Li-Hong Bai, Can-Mao Xie, Ke-Jing Tang
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Kodamaea ohmeri is a rare pathogen with high mortality and is found among blood samples in a considerable proportion; however, gastrointestinal infection of K. ohmeri is extremely rare. Invasive pulmonary aspergillosis is also an
Externí odkaz:
https://doaj.org/article/b0d94d5843264db3bbd8b329022be28c
Publikováno v:
Journal of Acute Disease, Vol 7, Iss 1, Pp 45-48 (2018)
Hemoptysis is a common emergency symptom for pulmonary embolism. It's important to differential diagnosis for this symptom. This article reports a case of pulmonary vein stenosis. The patient was transferred to a number of hospitals for medical treat
Externí odkaz:
https://doaj.org/article/ebf1591529c246e9ad3676c9718cb784
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology. 321:L6-L16
Macrophage migration inhibitory factor (MIF) inhibition can attenuate pulmonary fibrosis, but the antifibrotic mechanism is unclear. Here we investigated the antifibrotic effect of MIF knockdown in rats with bleomycin (BLM)-induced pulmonary fibrosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92556b713ac323d120365e5a69603c1f
https://doi.org/10.1152/ajplung.00288.2020
https://doi.org/10.1152/ajplung.00288.2020
Autor:
Xue Sun, Li-Hong Bai, Pei-Hang Xu, Yu-Kun Kuang, Yi-Fan Zheng, Ji-Yu Wang, Zi-Mu Li, Run-Jing Gan, Ke-Jing Tang
Background: FAM83A (Family with sequence similarity 83, member A) has been found to promote tumor cell proliferation and accelerate the progression of several cancer types. However, integrated studies on the prognostic value of FAM83A and its functio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4058bbd7812a776621c3e269cf6af7c
https://doi.org/10.21203/rs.3.rs-1526469/v1
https://doi.org/10.21203/rs.3.rs-1526469/v1
Autor:
Yi-Fan Zheng, Pei-Hang Xu, Zi-mu Li, Yu-Kun Kuang, Jia Li, Jun-Hao He, Xiao Chen, Ke-Jing Tang
Publikováno v:
Journal of Clinical Oncology. 40:e14587-e14587
e14587 Background: Pneumonitis is one of the most common fatal pulmonary adverse events that stem from immune checkpoint inhibitors (ICIs). Although the combination of ICI plus chemotherapy has become the standard first-line treatment regiments for v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11b3952f9993a92a00a82d408afad77c
https://doi.org/10.1200/jco.2022.40.16_suppl.e14587
https://doi.org/10.1200/jco.2022.40.16_suppl.e14587
Publikováno v:
Journal of Clinical Oncology. 40:2655-2655
2655 Background: Clinical trials lack direct cross-comparison in safety between immune checkpoint inhibitor (ICI) as monotherapy and in combination with chemotherapy. The adverse event of checkpoint inhibitor pneumonitis (CIP) is an important factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7a934fe30f5fc88146231728206f69b
https://doi.org/10.1200/jco.2022.40.16_suppl.2655
https://doi.org/10.1200/jco.2022.40.16_suppl.2655
Publikováno v:
The Clinical Respiratory Journal. 8:41-44
Introduction In patients with refractory pleural effusion or pneumothorax, fever and elevated level of white blood cell count (WBC) are frequently observed after chemical pleurodesis with intrapleural injection of OK-432, which make it difficult to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92ec39957cdc08916b4dcaf598fec9fe
https://doi.org/10.1111/crj.12032
https://doi.org/10.1111/crj.12032